Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (28)
Alexander Bollenbach, Aletta E. Schutte, Ruan Kruger & Dimitrios Tsikas. (2020) An Ethnic Comparison of Arginine Dimethylation and Cardiometabolic Factors in Healthy Black and White Youth: The ASOS and African-PREDICT Studies. Journal of Clinical Medicine 9:3, pages 844.
Crossref
Crossref
Sotirios Tsalamandris, Evangelos Oikonomou, Nikolaos Papageorgiou & Dimitris Tousoulis. 2018. Coronary Artery Disease. Coronary Artery Disease
67
94
.
Joëlle Magné, Jean-François Huneau, Didier Borderie, Véronique Mathé, Cécile Bos & François Mariotti. (2015) Plasma asymmetric and symmetric dimethylarginine in a rat model of endothelial dysfunction induced by acute hyperhomocysteinemia. Amino Acids 47:9, pages 1975-1982.
Crossref
Crossref
Arslan Arinc Kayacelebi, Janina Willers, Vu Vi Pham, Andreas Hahn, Jessica Y. Schneider, Sabine Rothmann, Jürgen C. Frölich & Dimitrios Tsikas. (2015) Plasma homoarginine, arginine, asymmetric dimethylarginine and total homocysteine interrelationships in rheumatoid arthritis, coronary artery disease and peripheral artery occlusion disease. Amino Acids 47:9, pages 1885-1891.
Crossref
Crossref
Serkan Zincir, Selma Bozkurt Zincir, Ali Doruk, Murat Erdem, Cemil Celik, Mehmet Ak, Beyazıt Garip, Cihad Yükselir & Bülent Karaahmetoğlu. (2014) Asymmetric dimethylarginine (ADMA) and treatment response relationship in male patients with first-episode schizophrenia: A controlled study. Psychiatry Research 220:1-2, pages 76-80.
Crossref
Crossref
Oğuzhan Öz, Mehmet Yücel, Hakan Akgün, Zeki Gökçil & Zeki Odabaşı. (2012) Increased asymmetric dimethylarginine level after antiepileptic drug treatment may be independent of the changes in plasma homocysteine level. Seizure 21:3, pages 232.
Crossref
Crossref
Aleksandra Sniezawska, Jolanta Dorszewska, Agata Rozycka, Elzbieta Przedpelska-Ober, Margarita Lianeri, Pawel P. Jagodzinski & Wojciech Kozubski. (2011) MTHFR, MTR, and MTHFD1 gene polymorphisms compared to homocysteine and asymmetric dimethylarginine concentrations and their metabolites in epileptic patients treated with antiepileptic drugs. Seizure 20:7, pages 533-540.
Crossref
Crossref
Elisabetta Trabetti. (2008) Homocysteine,MTHFR gene polymorphisms, and cardio-cerebrovascular risk. Journal of Applied Genetics 49:3, pages 267-282.
Crossref
Crossref
Andreas Meinitzer, Markus Puchinger, Brigitte M. Winklhofer-Roob, Edmond Rock, Josep Ribalta, Johannes M. Roob, Isabella Sundl, Gabriele Halwachs-Baumann & Winfried März. (2007) Reference values for plasma concentrations of asymmetrical dimethylarginine (ADMA) and other arginine metabolites in men after validation of a chromatographic method. Clinica Chimica Acta 384:1-2, pages 141-148.
Crossref
Crossref
Mohamed M. Eldibany & Joseph A. Caprini. (2007) Hyperhomocysteinemia and Thrombosis: An Overview. Archives of Pathology & Laboratory Medicine 131:6, pages 872-884.
Crossref
Crossref
Andreas Meinitzer & Winfried März. (2007) Asymmetrisches Dimethylarginin (ADMA): ein neuer Marker zur Abschätzung des kardiovaskulären Risikos / Asymmetric dimethyl arginine (ADMA): a new marker for evaluating cardiovascular risk. LaboratoriumsMedizin 31:3, pages 125-134.
Crossref
Crossref
K. Schroecksnadel, G. Weiss, O. Stanger, T. Teerlink & D. Fuchs. (2007) Increased Asymmetric Dimethylarginine Concentrations in Stimulated Peripheral Blood Mononuclear Cells. Scandinavian Journal of Immunology 65:6, pages 525-529.
Crossref
Crossref
Andreas Meinitzer, Ursula Seelhorst, Britta Wellnitz, Gabriele Halwachs-Baumann, Bernhard O Boehm, Bernhard R Winkelmann & Winfried März. (2007) Asymmetrical Dimethylarginine Independently Predicts Total and Cardiovascular Mortality in Individuals with Angiographic Coronary Artery Disease (The Ludwigshafen Risk and Cardiovascular Health Study). Clinical Chemistry 53:2, pages 273-283.
Crossref
Crossref
Coen van Guldener, Prabath W.B. Nanayakkara & Coen D.A. Stehouwer. (2007) Homocysteine and asymmetric dimethylarginine (ADMA): biochemically linked but differently related to vascular disease in chronic kidney disease. Clinical Chemical Laboratory Medicine 45:12.
Crossref
Crossref
Andrzej Surdacki, Ewa Stochmal, Magdalena Szurkowska, Stefanie M. Bode-Böger, Jens Martens-Lobenhoffer, Anna Stochmal, Artur Klecha, Kalina Kawecka-Jaszcz, Jacek S. Dubiel, Bohdan Huszno & Zbigniew Szybiński. (2007) Nontraditional atherosclerotic risk factors and extent of coronary atherosclerosis in patients with combined impaired fasting glucose and impaired glucose tolerance. Metabolism 56:1, pages 77-86.
Crossref
Crossref
Katarzyna Krzyzanowska, Friedrich Mittermayer, Walter Krugluger, Christoph Schnack, Martin Hofer, Michael Wolzt & Guntram Schernthaner. (2006) Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes. Atherosclerosis 189:1, pages 236-240.
Crossref
Crossref
François Mariotti, Alexia Hammiche, Clémence Blouet, Sophie Daré, Daniel Tomé & Jean François Huneau. (2006) Medium-term methionine supplementation increases plasma homocysteine but not ADMA and improves blood pressure control in rats fed a diet rich in protein and adequate in folate and choline. European Journal of Nutrition 45:7, pages 383-390.
Crossref
Crossref
Michiel P. C. SiroenTom TeerlinkRobert J. NijveldtHubert A. PrinsMilan C. RichirPaul A.M. van Leeuwen. (2006) The Clinical Significance of Asymmetric Dimethylarginine. Annual Review of Nutrition 26:1, pages 203-228.
Crossref
Crossref
A. M. E. Spoelstra-de Man, T. Teerlink, C. B. Brouwer, J. A. Rauwerda, C. D. A. Stehouwer & Y. M. Smulders. (2006) No effect of B vitamins on ADMA levels in patients at increased cardiovascular risk. Clinical Endocrinology 64:5, pages 495-501.
Crossref
Crossref
M. O. VERHOEVEN, M. HEMELAAR, M. J. VAN DER MOOREN, P. KENEMANS & T. TEERLINK. (2006) Oral, more than transdermal, oestrogen therapy lowers asymmetric dimethylarginine in healthy postmenopausal women: a randomized, placebo-controlled study. Journal of Internal Medicine 259:2, pages 199-208.
Crossref
Crossref
David E. L. Wilcken, Jun Wang, Ah Siew Sim, Kathryn Green & Bridget Wilcken. (2006) Asymmetric dimethylarginine in homocystinuria due to cystathionine β‐synthase deficiency: Relevance of renal function. Journal of Inherited Metabolic Disease 29:1, pages 30-37.
Crossref
Crossref
Tom Teerlink. (2016) ADMA metabolism and clearance. Vascular Medicine 10:1_suppl, pages S73-S81.
Crossref
Crossref
Sanjana Dayal & Steven R Lentz. (2016) ADMA and hyperhomocysteinemia. Vascular Medicine 10:1_suppl, pages S27-S33.
Crossref
Crossref
Sanjana Dayal & Steven R Lentz. (2016) ADMA and hyperhomocysteinemia. Vascular Medicine 10:2_suppl, pages S27-S33.
Crossref
Crossref
Tom Teerlink. (2016) ADMA metabolism and clearance. Vascular Medicine 10:2_suppl, pages S73-S81.
Crossref
Crossref
Sagar Doshi, Ian McDowell, Jonathan Goodfellow, Sally Stabler, Rainer Boger, Robert Allen, Robert Newcombe, Malcolm Lewis & Stuart Moat. (2005) Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypohomocysteinemia. Metabolism 54:3, pages 351-360.
Crossref
Crossref
Tom Teerlink. (2005) Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance. Clinical Chemistry and Laboratory Medicine (CCLM) 43:10.
Crossref
Crossref
Patrick VallanceJames Leiper. (2004) Cardiovascular Biology of the Asymmetric Dimethylarginine:Dimethylarginine Dimethylaminohydrolase Pathway. Arteriosclerosis, Thrombosis, and Vascular Biology 24:6, pages 1023-1030.
Crossref
Crossref